Avalo Therapeutics, Inc.
AVTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534120
In the last 90 days, Avalo Therapeutics, Inc. insiders filed 0 open-market purchases and 9 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $1.31B in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Avalo Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- +2 vs. Q1 2025
- Shares held
- 7.84M
- −412.0K (−5.0%) vs. Q1 2025
- Total value
- $39.1M
- −$27.0M (−40.8%) vs. Q1 2025
- New holders
- 4
- 9 more added
- Sold out
- 2
- 12 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 126 | $1.31B |
| Q1 2026 | 97 | $469.6M |
| Q4 2025 | 84 | $361.1M |
| Q3 2025 | 66 | $194.7M |
| Q2 2025 | 36 | $39.1M |
| Q1 2025 | 34 | $66.1M |
| Q4 2024 | 33 | $56.0M |
| Q3 2024 | 29 | $63.2M |
| Q2 2024 | 21 | $9.62M |
| Q1 2024 | 18 | $1.90M |
| Q4 2023 | 12 | $209.4K |
| Q3 2023 | 28 | $158.9K |
| Q2 2023 | 26 | $862.7K |
| Q1 2023 | 32 | $16.0M |
| Q4 2022 | 28 | $28.0M |
| Q3 2022 | 27 | $18.4M |
| Q2 2022 | 54 | $34.7M |
| Q1 2022 | 71 | $56.2M |
| Q4 2021 | 75 | $136.0M |
| Q3 2021 | 77 | $175.5M |
| Q2 2021 | 71 | $218.1M |
| Q1 2021 | 70 | $180.4M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Avalo Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Avion Wealth | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 1 | $5 | 0.00% | −1−50.0% | Reduced |
| Parallel Advisors, LLC | 1 | $5 | 0.00% | 00.0% | Unchanged |
| Key Financial Inc | 1 | $5 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 1 | $5 | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Inc | 1 | $5 | 0.00% | +1 | New |
| Advisor Group Holdings, Inc. | 2 | $8 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 5 | $25 | 0.00% | +1+25.0% | Added |
| Morgan Stanley | 10 | $50 | 0.00% | −350−97.2% | Reduced |
| SBI Securities Co., Ltd. | 22 | $110 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 74 | $369 | 0.00% | −1,031−93.3% | Reduced |
| Allostery Investments LP | 9,000 | $44.9K | 0.57% | −98,141−91.6% | Reduced |
| Quadrature Capital Ltd | 10,976 | $54.8K | 0.00% | +10,976 | New |
| Boothbay Fund Management, LLC | 11,321 | $56.5K | 0.00% | +11,321 | New |
| Two Sigma Investments, LP | 12,889 | $64.3K | 0.00% | +12,889 | New |
| Walleye Capital LLC | 20,613 | $102.9K | 0.00% | +390+1.9% | Added |
| Northern Trust Corp | 22,673 | $113.1K | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 35,300 | $176.1K | 0.06% | −164,700−82.4% | Reduced |
| Sio Capital Management, LLC | 72,173 | $360.1K | 0.14% | +715+1.0% | Added |
| UBS Group AG | 83,724 | $417.8K | 0.00% | −15,227−15.4% | Reduced |
| ADAR1 Capital Management, LLC | 104,730 | $522.6K | 0.08% | +94,730+947.3% | Added |
| Geode Capital Management, LLC | 110,460 | $551.6K | 0.00% | +2,648+2.5% | Added |
| Perceptive Advisors LLC | 139,667 | $696.9K | 0.03% | −380,333−73.1% | Reduced |
| Velan Capital Investment Management LP | 154,972 | $773.3K | 0.77% | +43,000+38.4% | Added |
| BlackRock, Inc. | 155,899 | $777.9K | 0.00% | +22,173+16.6% | Added |
| Vanguard Group Inc | 166,941 | $833.0K | 0.00% | 00.0% | Unchanged |
| Adviser Investments LLC | 261,016 | $1.30M | 0.02% | −51,763−16.5% | Reduced |
| Bank of America Corp | 406,571 | $2.03M | 0.00% | +400,898+7,066.8% | Added |
| Commodore Capital LP | 483,000 | $2.41M | 0.17% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 483,000 | $2.41M | 0.28% | 00.0% | Unchanged |
| Deep Track Capital, LP | 567,103 | $2.83M | 0.09% | −292,773−34.0% | Reduced |
| Affinity Asset Advisors, LLC | 607,872 | $3.03M | 0.45% | −49,282−7.5% | Reduced |
| Ra Capital Management, L.P. | 932,973 | $4.66M | 0.08% | −34,027−3.5% | Reduced |
| OrbiMed Advisors LLC | 967,000 | $4.83M | 0.12% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 995,000 | $4.97M | 0.35% | +95,000+10.6% | Added |
| BVF Inc | 1,028,049 | $5.13M | 0.18% | −8,630−0.8% | Reduced |
| HRT Financial LP | 0 | $0 | 0.00% | −10,289−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −212−100.0% | Sold out |